Tumor-specific granulocyte/ macrophage colony-stimulating factor and interferon-gamma secretion is associated with in vivo therapeutic efficacy of activated tumor-draining lymph node cells, Cancer Immunol Immunother, vol.41, p.317, 1995. ,
Interferongamma and tumor necrosis factor have a role in tumor regression mediated by murine CD8 + tumor-infiltrating lymphocytes, J Exp Med, vol.173, p.647, 1991. ,
Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay, Nat Med, vol.7, p.1159, 2001. ,
Comprehensive analysis of the frequency of recognition of melanoma associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy, Eur J Immunol, vol.31, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482156
Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial, Cancer, vol.68, p.1, 1991. ,
Heterogeneity of biologic responses of melanoma-specific CTL, J Immunol, vol.159, p.2831, 1997. ,
Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study, J Clin Oncol, vol.13, p.1939, 1995. ,
Adoptive immunotherapy prevents prostate cancer in a transgenic animal model, Eur J Immunol, vol.29, p.1127, 1999. ,
Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells, Adv Immunol, vol.49, p.281, 1991. ,
, , 2000.
, Eradication of established tumors by CD8 + T cell adoptive immunotherapy, Immunity, vol.13, p.265
Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes, Nat Med, vol.2, p.551, 1996. ,
The central role of CD4(+) T cells in the antitumor immune response, J Exp Med, vol.188, p.2357, 1998. ,
Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4 + T cells, J Exp Med, vol.186, p.757, 1997. ,
High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J Immunother, vol.10, p.405, 1991. ,
Detection of intracellular cytokines by flow cytometry, J Immunol Methods, vol.159, p.197, 1993. ,
Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression, J Immunol, vol.154, p.3961, 1995. ,
A model for CD8 + CTL tumor immunosurveillance and regulation of tumor escape by CD4 T cells through an effect on quality of CTL, J Immunol, vol.163, p.184, 1999. ,
Adoptive immunotherapy mediated by anti-TCR/IL-2-activated tumour-draining lymph node cells, Immunology, vol.83, p.45, 1994. ,
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma, Proc Natl Acad Sci, vol.97, issue.5, p.2397, 1999. ,
, Proc Natl Acad Sci, vol.96, p.8633
High-scale expansion of melanoma reactive TIL by a polyclonal stimulus: predictability and relation with disease advancement, Cancer Immunol Immunother, vol.50, p.134, 2001. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482159
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma, New Engl J Med, vol.319, p.1676, 1988. ,
A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes, Science, vol.233, p.1318, 1986. ,
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2, 1994. ,
, J Natl Cancer Inst, vol.86, p.1159
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease, Blood, vol.91, p.2925, 1998. ,
IFN-gamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity, Nature, vol.410, p.1107, 2001. ,
Enhanced growth of primary tumors in cancer-prone mice after immunization against the mutant region of an inherited oncoprotein, J Exp Med, vol.191, p.1945, 2000. ,
Home therapy with autologous tumourinfiltrating lymphocytes and subcutaneous interleukin-2 in metastatic melanoma, 1996. ,
, CD4 T cells and their role in antitumor immune responses, vol.32, pp.735-763, 1999.
, J Exp Med, vol.189, p.753